April 21, 2017 by Sam Sholtis Penn State researchers identified 832 genes that have low coverage across multiple whole-exome sequencing platforms. These genes are associated with leukemia, psoriasis, heart failure and other diseases, and may be missed by researchers using whole-exome sequencing to study these diseases. Credit: Penn State University, Carley LaVelle <\/p>\n
Whole-exome DNA sequencinga technology that saves time and money by sequencing only protein-coding regions and not the entire genomemay routinely miss detecting some genetic variations associated with disease, according to Penn State researchers who have developed new ways to identify such omissions. <\/p>\n
Whole-exome sequencing has been used in many studies to identify genes associated with disease, and by clinical labs to diagnose patients with genetic disorders. However, the new research shows that these studies may routinely miss mutations in a subset of disease-causing genesassociated with leukemia, psoriasis, heart failure and othersthat occur in regions of the genome that are read less often by the cost-saving technology. A paper describing the research appeared online April 13 in the journal Scientific Reports. <\/p>\n
\"Although it was known that coveragethe average number of times a given piece of DNA is read during sequencingcould be uneven in whole-exome sequencing, our new methods are the first to really quantify this,\" said Santhosh Girirajan, assistant professor of biochemistry and molecular biology and of anthropology at Penn State and an author of the paper. \"Adequate coverageoften as many as 70 or more reads for each piece of DNAincreases our confidence that the sequence is accurate, and without it, it is nearly impossible to make confident predictions about the relationship between a mutation in a gene and a disease. In our study, we found 832 genes that have systematically low coverage across three different sequencing platforms, meaning that these genes would be missed in disease studies.\" <\/p>\n
The researchers developed two different methods to identify low-coverage regions in whole-exome sequence data. The first method identifies regions with inconsistent coverage compared to other regions in the genome from multiple samples. The second method calculates the number of low-coverage regions among different samples in the same study. They have packaged both methods into an open-source software for other researchers to use. <\/p>\n
\"Even when the average coverage in a whole-exome sequencing study was high, some regions appeared to have systematically low-coverage,\" said Qingyu Wang, a graduate student at Penn State at the time of the research and the first author of the paper. <\/p>\n
Low-coverage regions may result from limited precision in whole-exome sequencing technologies due to certain genomic features. Highly-repetitive stretches of DNAregions of the genome where the same simple sequence of As, Ts, Cs and Gs can be repeated many timescan prevent the sequencer from reading the DNA properly. Indeed, the study showed that at least 60 percent of low-coverage genes occur near DNA repeats. As an example, the gene MAST4 contains a repeated sequence element that leads to a three-fold reduction in coverage compared to non-repeating sequences. Even when other genes have sufficient coverage, this region of the MAST4 gene falls well below the recommended coverage to detect genetic variations in these studies. <\/p>\n
\"One solution to this problem is for researchers to use whole-genome sequencing, which examines all base pairs of DNA instead of just the regions that contain genes,\" said Girirajan. \"Our study found that whole-genome data had significantly fewer low-coverage genes than whole-exome data, and its coverage is more uniformly distributed across all parts of the genome. However, the costs of whole-exome sequencing are still significantly lower than whole-genome sequencing. Until the costs of whole-genome sequencing is no longer a barrier, human genetics researchers should be aware of these limitations in whole-exome sequencing technologies.\" <\/p>\n
Explore further: Whole genome or exome sequencing: An individual insight <\/p>\n
More information: Qingyu Wang et al. Novel metrics to measure coverage in whole exome sequencing datasets reveal local and global non-uniformity, Scientific Reports (2017). DOI: 10.1038\/s41598-017-01005-x<\/p>\n
Focusing on parts rather than the whole, when it comes to genome sequencing, might be extremely useful, finds research in BioMed Central's open access journal Genome Medicine. The research compares several sequencing technologies ... <\/p>\n
(Medical Xpress)An international team of researchers has developed a way to use RNA sequencing to help in diagnosing patients with rare genetic muscle conditions. In their paper published in the journal Science Translational ... <\/p>\n
Researchers have analysed 44 exome datasets from four different testing kits and shown that they missed a high proportion of clinically relevant regions. At least one gene in each exome method was missing more than 40 percent ... <\/p>\n
UCLA researchers have found that a state-of-the-art molecular genetic test greatly improves the speed and accuracy with which they can diagnose neurogenetic disorders in children and adults. The discovery could lead directly ... <\/p>\n
Published in today's edition of Nature, the research led by Dr Monkol Lek of the University of Sydney and Dr Daniel MacArthur of The Broad Institute of MIT and Harvard Universities reveals patterns of genetic variation worldwide ... <\/p>\n
A new study that assesses the accuracy of modern human-genome-sequencing technologies found that some medically significant portions of an individual's DNA blueprint are situated in complex, hard-to-analyze regions that are ... <\/p>\n
Whole-exome DNA sequencinga technology that saves time and money by sequencing only protein-coding regions and not the entire genomemay routinely miss detecting some genetic variations associated with disease, according ... <\/p>\n
Research published this week in Scientific Reports uses computer image and statistical shape analysis to shed light on which parts of the face are most likely to be inherited. <\/p>\n
Salk scientists and collaborators have shed light on a long-standing question about what leads to variation in stem cells by comparing induced pluripotent stem cells (iPSCs) derived from identical twins. Even iPSCs made from ... <\/p>\n
In a study published today in PLoS ONE, a team of researchers reports solving a medical mystery in a day's work. In record-time detective work, the scientists narrowed down the genetic cause of intellectual disability in ... <\/p>\n
After nearly 40 years of searching, Johns Hopkins researchers report they have identified a part of the human genome that appears to block an RNA responsible for keeping only a single X chromosome active when new female embryos ... <\/p>\n
It's not so hard anymore to find genetic variations in patients, said Brown University genomics expert William Fairbrother, but it remains difficult to understand whether and how those mutations undermine health. <\/p>\n
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more <\/p>\n
<\/p>\n
Originally posted here: April 21, 2017 by Sam Sholtis Penn State researchers identified 832 genes that have low coverage across multiple whole-exome sequencing platforms. These genes are associated with leukemia, psoriasis, heart failure and other diseases, and may be missed by researchers using whole-exome sequencing to study these diseases. Continue reading
\nDisease-associated genes routinely missed in some genetic studies - Medical Xpress<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"